Výsledky vyhledávání - M Beksac

P05 ACETYL SALICYLIC ACID INDUCES POLARIZATION OF MACROPHAGES AND CYTOTOXICITY ON MYELOMA CELLS IN VITRO Autor N. Gonulkirmaz, M. Beksac, T. Ozkan, I. Kar, A. Sunguroglu

Získat plný text

B02 | THE PROGNOSTIC IMPACT OF BONE MARROW PLASMA CELL INFILTRATION AT DIAGNOSIS IN AL AMYLOIDOSIS Autor K. Aslantaş, Ş. Özlü, I. Kuzu, M. Beksaç, G. Cengiz Seval

Získat plný text

P24 | APPROACHING CURE IN MULTIPLE MYELOMA: A DUAL-CENTER EXPERIENCE AMONG PATIENTS DIAGNOSED BEFORE 2010 Autor G. Cengiz Seval, H. Aytekin, T. Otlu, U. Calıs, M. Beksac

Získat plný text

P15 VALIDATION OF THE NOVEL EUROPEAN MYELOMA NETWORK PROGNOSTIC SCORE (R2-ISS) IN AN INDEPENDENT REAL-WORLD SETTING Autor G Cengiz Seval, M Aydoğan, MH Akbulut, B Karakaya, G Yavuz, H Yilmaz, M Beksac

Získat plný text

P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY Autor A. Oriol, M. Dimopoulos, F. Schjesvold, M. Beksac, M. Yagci, A. Larocca, S. Guo, Y. Mu, K. Hong, S. Dhanasiri, P. Richardson, K. Weisel

Získat plný text

P73 | TP53 MUTATION AND MSS-WM IDENTIFY HIGH RISK WALDENSTROM MACROGLOBULINEMIA IN A REAL WORLD COHORT Autor U. Calis, S. Yuksel, M. Kurt Yuksel, P. Topcuoglu, I. Kuzu, O. Arslan, M. Ozcan, T. Demirer, S. Kocak Toprak, M. Beksac, G. Cengiz Seval

Získat plný text

P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES Autor M Beksac, G Cengiz Seval, S Civriz Bozdag, SK Toprak, M Kurt Yuksel, P Topcuoglu, O Arslan, M Ozcan, T Demirer, O Ilhan, G Gurman

Získat plný text

PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA Autor O. Ilhan, G. Cengiz Seval, F. Avcu, B. Ferhanoglu, M. Ozcan, G. Cetin, E. Kurtoglu, H. Yilmaz, F. Atalay, E. Gulturk, M. Nalcaci, M. Beksac

Získat plný text

P04: DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE ALONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: OVERALL SURVIVAL RESULTS FROM THE... Autor P Sonneveld, A Chanan-Khan, K Weisel, AK Nooka, T Masszi, M Beksac, I Spicka, V Hungria, M Munder, MV Mateos, TM Mark, MD Levin, T Ahmadi, X Qin, W Garvin Mayo, X Gai, J Carey, R Carson, A Spencer

Získat plný text

C002 | SUBCUTANEOUS DARATUMUMAB + BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE WITH DARA + LENALIDOMIDE MAINTENANCE IN TRANSPLANT-ELIGIBLE PATIENTS WITH NDMM: ANALYSIS OF SUSTAINED MINIMA... Autor E. Antonioli, P. Moreau, P. Sonneveld, H. Einsele, H. Quach, P. Joy Ho, M. Beksac, C. Hulin, X. Leleu, S. Mangiacavalli, A. Perrot, M. Cavo, A. Belotti, A. Broijl, H. Pei, A. Sitthi-Amorn, R. L. Carson, P. Rodríguez-Otero, M.A. Dimopoulos, M. Boccadoro

Získat plný text

DP111 | POSITRON EMISSION TOMOGRAPHY WITH COMPUTED TOMOGRAPHY AND MINIMAL RESIDUAL DISEASE FOR EFFICACY ASSESSMENT IN TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MYELOMA PATIENTS: IMROZ... Autor E. Zamagni, T. Facon, M.A. Dimopoulos, X. Leleu, M. Beksac, L. Pour, R. Hajek, Z. Liu, J. Minarik, P. Moreau, J. Romejko-Jarosinska, I. Spicka, T.G. Martin, L. Qiu, C. Sachpekidis, E. Kodas, H. Van De Velde, L. Zhao, R. Orlowski, H. Goldschmidt

Získat plný text

P12 | SUBCUTANEOUS DARATUMUMAB (DARA) + BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE WITH DARA + LENALIDOMIDE MAINTENANCE IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MY... Autor P. Sonneveld, Ph. Moreau, H. Einsele, H. Quach, P.J. Ho, M. Beksac, C. Hulin, E. Antonioli, X. Leleu, S. Mangiacavalli, A. Perrot, M. Cavo, A. Belotti, A. Broijl, H. Pei, A. Sitthi-Amorn, R.L. Carson, P. Rodríguez-Otero, M.A. Dimopoulos, M. Boccadoro

Získat plný text

DP114 | ISATUXIMAB, BORTEZOMIB, LENALIDOMIDE, DEXAMETHASONE IN PATIENTS WITH TRANSPLANT-INELIGIBLE NEWLY DIAGNOSED MYELOMA AND PLASMACYTOMAS: IMROZ SUBGROUP ANALYSIS Autor E. Zamagni, T. Facon, M.A. Dimopoulos, X. Leleu, M. Beksac, L. Pour, R. Hajek, Z. Liu, J. Minarik, P. Moreau, J. Romejko-Jarosinska, I. Spicka, V. Vorobyev, T.G. Martin, L, Qiu, C. Sachpekidis, E. Kodas, Z. Klippel, U. Khan, H. Van De Velde, R. Z. Orlowski, H. Goldschmidt

Získat plný text

P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING... Autor R. Tilmont, I. Yakoub-Agha, D.-J. Eikema, N. Zinger, M. Haenel, N. Schaap, C. Herrera Arroyo, C. Schuermans, W. Bethge, M. Engelhardt, J. Kuball, M. Michieli, N. Schub, K. M. O. Wilson, J. H. Bourhis, M. V. Mateos, N. Robin, E. Jost, N. Kröger, J. M. Moraleda, S. Sica, P. J. Hayden, M. Beksac, S. Schönland, S. Manier

Získat plný text

B09 | DARATUMUMAB MONOTHERAPY VERSUS ACTIVE MONITORING IN PATIENTS WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA: "AQUILA" OUTCOMES BASED ON MAYO 2018/IMWG 2020 RISK STRATIFICATION,... Autor F. Schjesvold, P.M. Voorhees, M.A. Dimopoulos, Y.C. Cohen, V. Hungria, I. Sandhu, J. Lindsay, R.I. Baker, K. Suzuki, H. Kosugi, M-D. Levin, M. Beksac, K. Stockerl-Goldstein, H. Magen, A. Oriol, G. Mikala, G. Garate, K. Theunissen, I. Spicka, A.K. Mylin, S. Hallam, S. Bringhen, K. Uttervall, B. Pula, A.M. Khan, E. Medvedova, J.C. Ye, A.J. Cowan, Ph. Moreau, M-V. Mateos, H. Goldschmidt, D. Vieyra, A. Raval, L. Sha, L. Li, E. Rousseau, R.M. Dennis, R.L. Carson, S.V. Rajkumar

Získat plný text